REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 159 filers reported holding REVANCE THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 2.29 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,907,177 | -57.3% | 602,195 | -5.9% | 0.00% | -50.0% |
| Q2 2023 | $16,192,226 | -31.5% | 639,756 | -12.8% | 0.00% | -33.3% |
| Q1 2023 | $23,641,368 | +60.3% | 733,976 | -8.1% | 0.00% | +50.0% |
| Q4 2022 | $14,745,773 | -20.0% | 798,796 | +17.0% | 0.00% | -33.3% |
| Q3 2022 | $18,432,000 | +165.1% | 682,705 | +35.7% | 0.00% | +200.0% |
| Q2 2022 | $6,953,000 | -14.5% | 503,084 | +20.6% | 0.00% | 0.0% |
| Q1 2022 | $8,133,000 | +35.0% | 417,107 | +13.0% | 0.00% | 0.0% |
| Q4 2021 | $6,023,000 | -23.5% | 369,087 | +30.6% | 0.00% | 0.0% |
| Q3 2021 | $7,873,000 | -8.6% | 282,610 | -2.8% | 0.00% | 0.0% |
| Q2 2021 | $8,617,000 | +82.9% | 290,724 | +72.5% | 0.00% | 0.0% |
| Q1 2021 | $4,711,000 | +9.4% | 168,580 | +10.9% | 0.00% | 0.0% |
| Q4 2020 | $4,308,000 | +92.8% | 151,964 | +71.0% | 0.00% | – |
| Q3 2020 | $2,234,000 | -7.8% | 88,843 | -10.5% | 0.00% | -100.0% |
| Q2 2020 | $2,422,000 | +417.5% | 99,214 | +213.4% | 0.00% | – |
| Q1 2020 | $468,000 | -67.9% | 31,657 | -64.8% | 0.00% | – |
| Q4 2019 | $1,459,000 | +303.0% | 89,888 | +222.9% | 0.00% | – |
| Q3 2019 | $362,000 | +358.2% | 27,839 | +358.8% | 0.00% | – |
| Q2 2019 | $79,000 | -95.4% | 6,068 | -94.4% | 0.00% | – |
| Q1 2019 | $1,706,000 | -44.7% | 108,216 | -29.4% | 0.00% | -100.0% |
| Q4 2018 | $3,084,000 | -19.2% | 153,246 | -0.2% | 0.00% | 0.0% |
| Q3 2018 | $3,815,000 | -24.0% | 153,540 | -16.0% | 0.00% | 0.0% |
| Q2 2018 | $5,017,000 | -4.4% | 182,759 | +7.3% | 0.00% | 0.0% |
| Q1 2018 | $5,248,000 | -35.6% | 170,401 | -25.3% | 0.00% | -50.0% |
| Q4 2017 | $8,151,000 | +133.4% | 228,008 | +79.9% | 0.00% | +100.0% |
| Q3 2017 | $3,493,000 | -26.1% | 126,772 | -29.2% | 0.00% | 0.0% |
| Q2 2017 | $4,728,000 | -26.1% | 179,091 | -41.7% | 0.00% | 0.0% |
| Q1 2017 | $6,394,000 | -14.8% | 307,340 | -15.2% | 0.00% | 0.0% |
| Q4 2016 | $7,506,000 | +298.4% | 362,592 | +211.9% | 0.00% | 0.0% |
| Q3 2016 | $1,884,000 | +53.8% | 116,265 | +29.1% | 0.00% | – |
| Q2 2016 | $1,225,000 | -6.6% | 90,037 | +19.7% | 0.00% | -100.0% |
| Q1 2016 | $1,312,000 | +84.5% | 75,196 | +261.5% | 0.00% | – |
| Q4 2015 | $711,000 | +570.8% | 20,799 | +484.2% | 0.00% | – |
| Q3 2015 | $106,000 | -94.4% | 3,560 | -94.0% | 0.00% | -100.0% |
| Q2 2015 | $1,900,000 | +1201.4% | 59,420 | +743.2% | 0.00% | – |
| Q1 2015 | $146,000 | +31.5% | 7,047 | +7.7% | 0.00% | – |
| Q4 2014 | $111,000 | -3.5% | 6,541 | +10.8% | 0.00% | – |
| Q3 2014 | $115,000 | -25.3% | 5,906 | +30.9% | 0.00% | – |
| Q2 2014 | $154,000 | -92.2% | 4,513 | -92.8% | 0.00% | -100.0% |
| Q1 2014 | $1,979,000 | – | 62,820 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Essex Woodlands Management, Inc. | 3,342,047 | $94,714,000 | 24.58% |
| Palo Alto Investors LP | 2,673,313 | $75,762,000 | 3.97% |
| Evolutionary Tree Capital Management, LLC | 89,348 | $2,532,000 | 1.93% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,121,152 | $31,773,000 | 1.12% |
| ArrowMark Colorado Holdings LLC | 2,964,135 | $84,004,000 | 0.65% |
| Rhenman & Partners Asset Management AB | 220,000 | $6,235,000 | 0.51% |
| Fosun International Ltd | 233,841 | $6,627,000 | 0.43% |
| OSTERWEIS CAPITAL MANAGEMENT INC | 174,970 | $4,959,000 | 0.30% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 76,671 | $2,173,000 | 0.27% |
| Tekla Capital Management LLC | 213,808 | $6,059,000 | 0.21% |